Seeing Is Believing
Currently out of the existing stock ratings of Yi Chen, 407 are a BUY (90.04%), 43 are a HOLD (9.51%), 2 are a SELL (0.44%).
Analyst Yi Chen, carries an average stock price target met ratio of 35.37% that have a potential upside of 51.74% achieved within 158 days. Previously, Yi Chen worked at HC WAINWRIGHT.
Yi Chen’s has documented 842 price targets and ratings displayed on 43 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RGNX, Regenxbio at 21-Mar-2025.
Analyst best performing recommendations are on CELC (CELCUITY LLC).
The best stock recommendation documented was for KPRX (KIORA PHARMACEUTICALS) at 7/11/2022. The price target of $100 was fulfilled within 3 days with a profit of $60.56 (37.72%) receiving and performance score of 125.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
10 months 24 days ago
(03-May-2024)
2/5 (40%)
$13.4 (372.22%)
248
Buy
$15
1 years 14 days ago
(13-Mar-2024)
1/9 (11.11%)
$11.06 (280.71%)
11
Which stock is Yi Chen is most bullish on?
Which stock is Yi Chen is most reserved on?
What Year was the first public recommendation made by Yi Chen?